🟢 20/20 Biolabs is trading 5% up in after-hours trading amid broader market strength

20/20 Biolabs is trading at $0.24, up 5.26% after-hours following a regular-session close of $0.23; no specific cause is confirmed.

• Recent closes fluctuated between $0.21 and $0.25.
• Broad sentiment was strongly positive on November 4, with major U.S. indexes up; biotech strength is context, not confirmation of the move’s cause.
• The company had announced a November 4 investor webinar; its notice said the session would not cover Q3 results or disclose material nonpublic information.